process
how is it made?
Our process combines constituents of plasma, a proprietary chitosan, and other ingredients into a various formulations and material states. These products are pathogen inactivated using multiple technologies and all plasma is collected from FDA-licensed blood center partners.
learn more about:
our platform
Our platform leverages plasma from donated human blood and a proprietary antimicrobial molecule (form of chitosan). The tissue-repairing benefits of plasma-derived products, combined with the sustained action of chitosan, may provide relief and long-lasting therapeutic action.
our products
Our therapeutic formulation is suitable for a variety of products, including liquid eye drops, gels, ointments, contact lenses, contoured bandages, and wound dressings. We believe this formulation will promote healing of epithelial (surface cell) disorders, such as dry eye disease, ophthalmic burns, and chronic wounds.
